[go: up one dir, main page]

IL159632A0 - Process and intermediates to prepare latanoprost - Google Patents

Process and intermediates to prepare latanoprost

Info

Publication number
IL159632A0
IL159632A0 IL15963202A IL15963202A IL159632A0 IL 159632 A0 IL159632 A0 IL 159632A0 IL 15963202 A IL15963202 A IL 15963202A IL 15963202 A IL15963202 A IL 15963202A IL 159632 A0 IL159632 A0 IL 159632A0
Authority
IL
Israel
Prior art keywords
intermediates
latanoprost
prepare
prepare latanoprost
Prior art date
Application number
IL15963202A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IL159632A0 publication Critical patent/IL159632A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
IL15963202A 2001-07-17 2002-06-24 Process and intermediates to prepare latanoprost IL159632A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30602601P 2001-07-17 2001-07-17
PCT/US2002/020188 WO2003008368A1 (en) 2001-07-17 2002-06-24 Process and intermediates to prepare latanoprost

Publications (1)

Publication Number Publication Date
IL159632A0 true IL159632A0 (en) 2004-06-01

Family

ID=23183414

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15963202A IL159632A0 (en) 2001-07-17 2002-06-24 Process and intermediates to prepare latanoprost

Country Status (16)

Country Link
US (1) US6689901B2 (es)
EP (1) EP1406854A1 (es)
JP (2) JP2004535465A (es)
KR (2) KR100602549B1 (es)
CN (1) CN1263726C (es)
AR (1) AR034797A1 (es)
BR (1) BR0211204A (es)
CA (1) CA2453631A1 (es)
HK (1) HK1065781A1 (es)
IL (1) IL159632A0 (es)
MX (1) MXPA04000473A (es)
PL (1) PL366372A1 (es)
RU (2) RU2267480C2 (es)
TW (1) TWI242551B (es)
WO (1) WO2003008368A1 (es)
ZA (1) ZA200400163B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143477A (en) * 2001-05-31 2009-07-20 Finetech Pharmaceutical Ltd Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives
IL134241A (en) 2000-01-27 2006-06-11 Finetech Pharmaceutical Ltd Process for the preparation of latanoprost
KR100437873B1 (ko) 2001-05-08 2004-06-26 연성정밀화학(주) 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질
GB0112699D0 (en) * 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
GB0329379D0 (en) * 2003-12-19 2004-01-21 Johnson Matthey Plc Prostaglandin synthesis
US7109371B2 (en) * 2004-01-05 2006-09-19 Johnson Matthey Public Limited Company Prostaglandin synthesis
KR101437302B1 (ko) * 2006-02-07 2014-09-02 가부시키가이샤 아루떼꾸 우에노 프로스타글란딘 유도체의 제조 방법
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
CN101555221B (zh) * 2008-04-09 2013-01-23 明德国际仓储贸易(上海)有限公司 一种前列腺素f型衍生物的制造方法
EP2143712A1 (en) * 2008-07-10 2010-01-13 Sandoz AG Improved Process for the Production of Prostaglandins and Prostaglandin Analogs
IT1392492B1 (it) 2008-12-24 2012-03-09 Ind Chimica Srl Processo per la purificazione del latanoprost, analogo sintetico della prostaglandina pgf2alfa.
WO2011095990A2 (en) 2010-02-03 2011-08-11 Fdc Limited Process for the purification of prostaglandins and analogues thereof
EP2495235B1 (en) 2011-03-04 2015-08-05 Newchem S.p.A. Process for the synthesis of prostaglandins and intermediates thereof
HUE033642T2 (en) * 2011-06-02 2017-12-28 Chinoin Zrt A new method for the destruction of prostaglandin amides
WO2013026149A1 (en) * 2011-08-24 2013-02-28 Apotex Pharmachem Inc. Dimethyl-(3,3-difluoro-2,2-dihydroxyheptyl)phosphonate and processes for its preparation
JP2012246301A (ja) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Ｆ系プロスタグランジン類を調製する方法
US9913849B2 (en) 2014-01-10 2018-03-13 Manistee Partners Llc Treatment of migraines
HU231214B1 (hu) * 2014-03-13 2021-11-29 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás nagytisztaságú prosztaglandinok előállítására
CN112142703A (zh) * 2020-09-30 2020-12-29 东北制药集团股份有限公司 一种卡前列素氨丁三醇相关杂质左旋丁基15-酮及其制备方法
CN112608294B (zh) * 2020-12-16 2021-10-26 西安国康瑞金制药有限公司 一种拉坦前列腺素的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2062102T5 (es) 1988-09-06 2004-12-01 Pharmacia Ab Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
CA2050820A1 (en) * 1990-09-24 1992-03-25 Pamela M. Simpson In-situ preparation of diisopinocamphenyl chloroborane
US5545758A (en) * 1994-08-11 1996-08-13 Merck & Co., Inc. Process for the preparation of diisopinocampheylchloroborane
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
HU223345B1 (hu) * 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
WO1998030900A2 (en) 1997-01-06 1998-07-16 Klaus Trier Aps Screening method for compounds active in treating myopia and hypermetropia
WO1999016756A1 (fr) * 1997-09-29 1999-04-08 Nippon Kayaku Kabushiki Kaisha Preparation de derives de nucleosides carbocycliques et intermediaires correspondants
AU2001261019A1 (en) * 2000-05-15 2001-11-26 Pharmacia And Upjohn Company Process and intermediates to prepare latanoprost

Also Published As

Publication number Publication date
JP2004535465A (ja) 2004-11-25
US20030045571A1 (en) 2003-03-06
TWI242551B (en) 2005-11-01
AR034797A1 (es) 2004-03-17
US6689901B2 (en) 2004-02-10
ZA200400163B (en) 2005-01-10
MXPA04000473A (es) 2004-12-06
RU2267480C2 (ru) 2006-01-10
EP1406854A1 (en) 2004-04-14
JP2007016050A (ja) 2007-01-25
HK1065781A1 (en) 2005-03-04
CN1533372A (zh) 2004-09-29
PL366372A1 (en) 2005-01-24
BR0211204A (pt) 2004-07-13
RU2004101053A (ru) 2005-06-27
KR100602549B1 (ko) 2006-07-20
CN1263726C (zh) 2006-07-12
RU2005123682A (ru) 2007-01-27
KR20060006980A (ko) 2006-01-20
CA2453631A1 (en) 2003-01-30
WO2003008368A1 (en) 2003-01-30
KR100581647B1 (ko) 2006-05-22
KR20040018457A (ko) 2004-03-03

Similar Documents

Publication Publication Date Title
IL159632A0 (en) Process and intermediates to prepare latanoprost
GB0103973D0 (en) Improvements relating to skin prickers
GB0106247D0 (en) Improvements relating to supports
HUP0402247A3 (en) Antibodies to cd40
AU2001294549A1 (en) Process and intermediates
GB0103977D0 (en) Improvements relating to skin prickers
AU2002359659A8 (en) Cross reference to related application
GB0222909D0 (en) Novel process and intermediates
GB0123961D0 (en) Process and intermediates
EP1406855A4 (en) NOVEL PROCESS FOR THE PREPARATION OF RAC-BICALUTAMIDE AND INTERMEDIATE PRODUCTS THEREOF
GB0222912D0 (en) Novel process and intermediates
TW444674U (en) Improved structure of ornament
GB0115581D0 (en) Method of mass spectometry
AU2001261019A1 (en) Process and intermediates to prepare latanoprost
PL345527A1 (en) Method of makinbg glassware
GB0112902D0 (en) Improvement to tyres
HUP0203543A3 (en) Process to prepare aryltriazolinones and novel intermediates thereto
GB0113298D0 (en) Purification process and intermediates
AU2003223295A1 (en) Process and intermediates to substituted imidazopyrimidines
TW493722U (en) Improved structure of lampwick
GB0013204D0 (en) Novel process and intermediates
GB0126076D0 (en) Improvements relating to prostaglandins and their analogues
GB0126075D0 (en) Improvements relating to prostaglandins and their analogues
PL339890A1 (en) Method of obtaining 4-chloro-n-(2-morpholinethyl)-benzamide
PL350101A1 (en) Method of obtaining 1-bromoethane acetate